Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Diamond Headache Clinic Identifier:
First received: May 8, 2007
Last updated: April 24, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)